GOP Senator Who Helped Federally Legalize Hemp Is Seeking To Close 'Loophole' By Banning Products With Committee Vote This Week, Sources Say

Senator Mitch McConnell is reportedly championing new agriculture spending legislation, set for a Senate Appropriations Committee vote this week, that would effectively ban all consumable hemp products containing any quantifiable amount of THC. This move, intended to close a perceived loophole from the 2018 Farm Bill that led to unregulated intoxicating cannabinoid products, poses an existential threat to the American hemp industry, including most CBD products which contain trace THC. Industry stakeholders, including Senator Rand Paul and the Wine & Spirits Wholesalers of America, warn this measure would devastate the market and create significant regulatory chaos.

Analysis

A significant legislative risk is materializing for the U.S. hemp industry, spearheaded by Senator Mitch McConnell, who originally championed the 2018 Farm Bill that legalized the crop. Forthcoming language in an agriculture spending bill, scheduled for a committee vote this week, seeks to ban all consumable products containing any "quantifiable" amount of THC. This measure is intended to close a perceived "loophole" that allowed for the proliferation of unregulated, intoxicating cannabinoids like delta-8 THC. However, the proposal's impact would be far broader, effectively threatening what Senator Rand Paul described as the potential "destruction" of the entire American hemp industry. Because the extraction process for non-intoxicating CBD almost invariably leaves trace amounts of THC, the ban would likely render most CBD products illegal, decimating a multibillion-dollar market. The move faces opposition from industry groups like the U.S. Hemp Roundtable, which advocates for regulation over prohibition, and even the Wine & Spirits Wholesalers of America, which proposes a more targeted ban on synthetic cannabinoids. The legislation does, however, include a specific carve-out for FDA-approved drugs, shielding pharmaceutical products like Epidiolex from its reach.

Key Decisions for Investors

• Re-evaluate all exposure to the U.S. hemp-derived cannabinoid supply chain, as the proposed federal ban on products with any 'quantifiable' THC represents an existential threat to the current business models of cultivators, processors, and retailers.
• Closely monitor the progress of the agriculture spending bill through the Senate Appropriations Committee this week, as its passage would serve as a strong signal to exit or significantly reduce positions in the sector.
• Consider the strategic implications for adjacent industries, as a ban could benefit the state-legal cannabis market by consolidating demand and the alcohol industry by removing what a Bloomberg Intelligence report identified as a 'significant threat'.